UK IVF Couples Turn to Dubious 'Smart Baby' Loophole to Pick Healthier, Smarter Kids
Families undergoing In Vitro Fertilization (IVF) in the UK are exploiting a loophole under data protection laws to send their embryo DNA abroad for analysis, allegedly to predict and select genetically superior offspring. The screening technique is banned by British fertility clinics due to scientific and ethical concerns.
The practice involves parents paying Β£50,000 to a US company called Herasight, which claims to deliver an average gain of six IQ points in children born from the selected embryos. In return for their data, couples receive genetic predictions about traits such as height, health risks, and intelligence quotient.
Critics argue that polygenic testing for embryo selection is unproven, raises concerns about unequal access to 'better' genes and a stratified society, and disregards existing laws governing IVF in the UK. However, under data protection regulations, patients can demand their embryos' raw genetic data without clinics being allowed to use it.
Dr Cristina Hickman, an embryologist at Avenues fertility clinic in London, says that rapid advances in embryo screening have left clinics facing "legal and ethical confusion." Despite her concerns, some couples have expressed willingness to pay for polygenic testing as a means of increasing their chances of producing healthier, smarter children.
In the UK, tests on embryos are limited to serious health conditions. However, if parents bank embryos under data protection laws, they can send them abroad for analysis. This raises questions about accountability and enforcement by the Human Fertilisation and Embryology Authority (HFEA). While some clinics have raised objections to the practice, others claim that blocking a couple's request would be against medical safety.
Several experts have condemned polygenic testing as unethical. Dr Angus Clarke of Cardiff University says that these companies deal in "murky science" where parents' expectations may not align with the reality of their genetic predictions.
Families undergoing In Vitro Fertilization (IVF) in the UK are exploiting a loophole under data protection laws to send their embryo DNA abroad for analysis, allegedly to predict and select genetically superior offspring. The screening technique is banned by British fertility clinics due to scientific and ethical concerns.
The practice involves parents paying Β£50,000 to a US company called Herasight, which claims to deliver an average gain of six IQ points in children born from the selected embryos. In return for their data, couples receive genetic predictions about traits such as height, health risks, and intelligence quotient.
Critics argue that polygenic testing for embryo selection is unproven, raises concerns about unequal access to 'better' genes and a stratified society, and disregards existing laws governing IVF in the UK. However, under data protection regulations, patients can demand their embryos' raw genetic data without clinics being allowed to use it.
Dr Cristina Hickman, an embryologist at Avenues fertility clinic in London, says that rapid advances in embryo screening have left clinics facing "legal and ethical confusion." Despite her concerns, some couples have expressed willingness to pay for polygenic testing as a means of increasing their chances of producing healthier, smarter children.
In the UK, tests on embryos are limited to serious health conditions. However, if parents bank embryos under data protection laws, they can send them abroad for analysis. This raises questions about accountability and enforcement by the Human Fertilisation and Embryology Authority (HFEA). While some clinics have raised objections to the practice, others claim that blocking a couple's request would be against medical safety.
Several experts have condemned polygenic testing as unethical. Dr Angus Clarke of Cardiff University says that these companies deal in "murky science" where parents' expectations may not align with the reality of their genetic predictions.